Financial Statements and Related Announcement::Third Quarter Results

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
Financial Statements and Related Announcement
Date &Time of Broadcast
08-Feb-2018 19:06:17
Status
New
Announcement Sub Title
Third Quarter Results
Announcement Reference
SG180208OTHR9W4A
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
08/02/2018 16:00:00
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
Sub- Outcome of the Board Meeting February 8, 2018

We wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the Third Quarter and Nine Months ended December 31, 2017.

The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith.

These are also being made available on the website of the Company at www.glenmarkpharma.com.

You are requested to take the same on record.

Additional Details

For Financial Period Ended
31/12/2017

Attachments

SGX_Results.pdf
Total size =1472K